| 1 | The effects of loss of Y chromosome on male health | 34.2 | 13 | Citations (PDF) |
| 2 | DNA methylation patterns contribute to changes of cellular differentiation pathways in leukocytes with LOY from patients with Alzheimer´s disease | 5.6 | 2 | Citations (PDF) |
| 3 | Mosaic Loss of Chromosome Y Is Associated With Functional Outcome After Ischemic Stroke | 5.1 | 12 | Citations (PDF) |
| 4 | Comprehensive cancer-oriented biobanking resource of human samples for studies of post-zygotic genetic variation involved in cancer predisposition | 2.5 | 8 | Citations (PDF) |
| 5 | High prevalence of somatic PIK3CA and TP53 pathogenic variants in the normal mammary gland tissue of sporadic breast cancer patients revealed by duplex sequencing | 6.7 | 23 | Citations (PDF) |
| 6 | Loss of Y in leukocytes as a risk factor for critical COVID-19 in men | 10.1 | 25 | Citations (PDF) |
| 7 | Immune cells lacking Y chromosome show dysregulation of autosomal gene expression | 5.6 | 88 | Citations (PDF) |
| 8 | Leukocytes with chromosome Y loss have reduced abundance of the cell surface immunoprotein CD99 | 3.7 | 41 | Citations (PDF) |
| 9 | Loss of Y and clonal hematopoiesis in blood—two sides of the same coin? | 8.2 | 40 | Citations (PDF) |
| 10 | Variable degree of mosaicism for tetrasomy 18p in phenotypically discordant monozygotic twins—Diagnostic implications | 1.7 | 10 | Citations (PDF) |
| 11 | Genetic predisposition to mosaic Y chromosome loss in blood | 34.3 | 290 | Citations (PDF) |
| 12 | Longitudinal changes in the frequency of mosaic chromosome Y loss in peripheral blood cells of aging men varies profoundly between individuals | 3.6 | 83 | Citations (PDF) |
| 13 | PRR14L mutations are associated with chromosome 22 acquired uniparental disomy, age-related clonal hematopoiesis and myeloid neoplasia | 8.2 | 15 | Citations (PDF) |
| 14 | Mosaic loss of chromosome Y in leukocytes matters | 26.1 | 69 | Citations (PDF) |
| 15 | Loss of Chromosome Y in Leukocytes and Major Cardiovascular Events | 5.2 | 6 | Citations (PDF) |
| 16 | Mosaic Loss of Chromosome Y in Blood Is Associated with Alzheimer Disease | 6.5 | 232 | Citations (PDF) |
| 17 | Mosaicism in health and disease — clones picking up speed | 34.2 | 247 | Citations (PDF) |
| 18 | Concurrent DNA Copy-Number Alterations and Mutations in Genes Related to Maintenance of Genome Stability in Uninvolved Mammary Glandular Tissue from Breast Cancer Patients | 4.1 | 18 | Citations (PDF) |
| 19 | Signatures of post-zygotic structural genetic aberrations in the cells of histologically normal breast tissue that can predispose to sporadic breast cancer | 4.7 | 32 | Citations (PDF) |
| 20 | Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer | 26.1 | 414 | Citations (PDF) |
| 21 | Non-heritable genetics of human disease: spotlight on post-zygotic genetic variation acquired during lifetime | 3.7 | 39 | Citations (PDF) |
| 22 | Republished: Non-heritable genetics of human disease: spotlight on post-zygotic genetic variation acquired during lifetime | 1.9 | 9 | Citations (PDF) |
| 23 | Post-Zygotic and Inter-Individual Structural Genetic Variation in a Presumptive Enhancer Element of the Locus between the IL10Rβ and IFNAR1 Genes | 2.5 | 2 | Citations (PDF) |
| 24 | Procoagulant activity in patients with sickle cell trait | 1.1 | 12 | Citations (PDF) |
| 25 | Age-Related Somatic Structural Changes in the Nuclear Genome of Human Blood Cells | 6.5 | 179 | Citations (PDF) |
| 26 | Common pathogenetic mechanism involving human chromosome 18 in familial and sporadic ileal carcinoid tumors | 3.4 | 91 | Citations (PDF) |
| 27 | Focal amplifications are associated with high grade and recurrences in stage Ta bladder carcinoma | 4.5 | 61 | Citations (PDF) |
| 28 | Somatic mosaicism for chromosome X and Y aneuploidies in monozygotic twins heterozygous for sickle cell disease mutation | 1.7 | 19 | Citations (PDF) |
| 29 | Frequent genetic differences between matched primary and metastatic breast cancer provide an approach to identification of biomarkers for disease progression | 3.6 | 42 | Citations (PDF) |
| 30 | Integrative epigenomic and genomic analysis of malignant pheochromocytoma | 11.6 | 34 | Citations (PDF) |
| 31 | Genome-wide microarray-based comparative genomic hybridization analysis of lymphoplasmacytic lymphomas reveals heterogeneous aberrations | 1.7 | 8 | Citations (PDF) |
| 32 | Characterization of novel and complex genomic aberrations in glioblastoma using a 32K BAC array | 0.9 | 44 | Citations (PDF) |
| 33 | Genome‐wide high‐resolution analysis of DNA copy number alterations in NF1‐associated malignant peripheral nerve sheath tumors using 32K BAC array | 3.4 | 53 | Citations (PDF) |
| 34 | Tissue-specific variation in DNA methylation levels along human chromosome 1 | 3.3 | 59 | Citations (PDF) |
| 35 | Profiling of copy number variations (CNVs) in healthy individuals from three ethnic groups using a human genome 32 K BAC-clone-based array | 4.1 | 47 | Citations (PDF) |
| 36 | Somatic mosaicism for copy number variation in differentiated human tissues | 4.1 | 187 | Citations (PDF) |
| 37 | Distal 22q11.2 microduplication encompassing the <i>BCR</i> gene | 1.7 | 31 | Citations (PDF) |
| 38 | Phenotypically Concordant and Discordant Monozygotic Twins Display Different DNA Copy-Number-Variation Profiles | 6.5 | 546 | Citations (PDF) |
| 39 | Autoantibodies to glutathione S-transferase theta 1 in patients with primary sclerosing cholangitis and other autoimmune diseases | 6.8 | 17 | Citations (PDF) |
| 40 | A segmental maximum a posteriori approach to genome-wide copy number profiling | 5.0 | 30 | Citations (PDF) |
| 41 | The Mechanism of Cystic Fibrosis Transmembrane Conductance Regulator Transcriptional Repression during the Unfolded Protein Response | 2.3 | 69 | Citations (PDF) |
| 42 | High-Resolution DNA Copy Number Profiling of Malignant Peripheral Nerve Sheath Tumors Using Targeted Microarray-Based Comparative Genomic Hybridization | 6.4 | 126 | Citations (PDF) |
| 43 | A previously unrecognized microdeletion syndrome on chromosome 22 band q11.2 encompassing the <i>BCR</i> gene | 1.7 | 44 | Citations (PDF) |
| 44 | Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus | 3.3 | 70 | Citations (PDF) |
| 45 | Analysis of copy number variation in the normal human population within a region containing complex segmental duplications on 22q11 using high-resolution array-CGH | 2.7 | 13 | Citations (PDF) |
| 46 | Chromosome 22 array-CGH profiling of breast cancer delimited minimal common regions of genomic imbalances and revealed frequent intra-tumoral genetic heterogeneity | 3.6 | 6 | Citations (PDF) |
| 47 | Microarray-based survey of CpG islands identifies concurrent hyper- and hypomethylation patterns in tissues derived from patients with breast cancer | 3.4 | 42 | Citations (PDF) |
| 48 | Detailed assessment of chromosome 22 aberrations in sporadic pheochromocytoma using array-CGH | 4.5 | 24 | Citations (PDF) |
| 49 | Identification of limited regions of genetic aberrations in patients affected with Wilms' tumor using a tiling-path chromosome 22 array | 4.5 | 10 | Citations (PDF) |
| 50 | Copy-number polymorphisms: mining the tip of an iceberg | 8.7 | 45 | Citations (PDF) |
| 51 | High‐resolution gene copy number and expression profiling of human chromosome 22 in ovarian carcinomas | 3.4 | 21 | Citations (PDF) |
| 52 | Localization of a putative low-penetrance ependymoma susceptibility locus to 22q11 using a chromosome 22 tiling-path genomic microarray | 3.4 | 26 | Citations (PDF) |
| 53 | Chromosome 22 tiling-path array-CGH analysis identifies germ-line- and tumor-specific aberrations in patients with glioblastoma multiforme | 3.4 | 34 | Citations (PDF) |
| 54 | Identification of genetic aberrations on chromosome 22 outside theNF2locus in schwannomatosis and neurofibromatosis type 2 | 4.1 | 29 | Citations (PDF) |
| 55 | High-resolution array-CGH profiling of germline and tumor-specific copy number alterations on chromosome 22 in patients affected with schwannomas | 3.1 | 20 | Citations (PDF) |
| 56 | Comprehensive DNA Copy Number Profiling of Meningioma Using a Chromosome 1 Tiling Path Microarray Identifies Novel Candidate Tumor Suppressor Loci | 0.6 | 44 | Citations (PDF) |
| 57 | Exon Array CGH: Detection of Copy-Number Changes at the Resolution of Individual Exons in the Human Genome | 6.5 | 133 | Citations (PDF) |
| 58 | DNA copy-number analysis of the 22q11 deletion-syndrome region using array-CGH with genomic and PCR-based targets | 4.1 | 15 | Citations (PDF) |
| 59 | LARGE can functionally bypass α-dystroglycan glycosylation defects in distinct congenital muscular dystrophies | 36.5 | 256 | Citations (PDF) |
| 60 | Genomic microarrays in the spotlight | 8.7 | 155 | Citations (PDF) |
| 61 | Molecular Recognition by LARGE Is Essential for Expression of Functional Dystroglycan | 28.6 | 257 | Citations (PDF) |
| 62 | NF2 Tumor Suppressor Gene: A Comprehensive and Efficient Detection of Somatic Mutations by Denaturing HPLC and Microarray-CGH | 3.8 | 12 | Citations (PDF) |
| 63 | Development of NF2 gene specific, strictly sequence defined diagnostic microarray for deletion detection | 3.7 | 31 | Citations (PDF) |
| 64 | Strong conservation of the human NF2 locus based on sequence comparison in five species | 2.5 | 7 | Citations (PDF) |
| 65 | Does chromosome 22 have anything to do with sex determination: Further studies on a 46,XX,22q11.2 del male | 2.2 | 11 | Citations (PDF) |
| 66 | Coincidence of synteny breakpoints with malignancy-related deletions on human chromosome 3 | 7.5 | 14 | Citations (PDF) |
| 67 | The transcriptional map of the common eliminated region 1 (C3CER1) in 3p21.3 | 3.6 | 39 | Citations (PDF) |
| 68 | A full-coverage, high-resolution human chromosome 22 genomic microarray for clinical and research applications | 3.1 | 132 | Citations (PDF) |
| 69 | Mouse cytosolic and mitochondrial deoxyribonucleotidases: cDNA cloning of the mitochondrial enzyme, gene structures, chromosomal mapping and comparison with the human orthologs | 2.4 | 10 | Citations (PDF) |
| 70 | Comparative human/murine sequence analysis of the common eliminated region 1 from human 3p21.3 | 2.5 | 18 | Citations (PDF) |
| 71 | The LZTFL1 Gene Is a Part of a Transcriptional Map Covering 250 kb within the Common Eliminated Region 1 (C3CER1) in 3p21.3 | 2.7 | 34 | Citations (PDF) |
| 72 | Analysis of short stature homeobox-containing gene ( SHOX ) and auxological phenotype in dyschondrosteosis and isolated Madelung deformity | 3.1 | 60 | Citations (PDF) |
| 73 | High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH | 3.1 | 149 | Citations (PDF) |
| 74 | A case of dermatofibrosarcoma protuberans of the vulva with a COL1A1/PDGFB fusion identical to a case of giant cell fibroblastoma | 3.1 | 46 | Citations (PDF) |
| 75 | Fine mapping of the constitutional translocation t(11;22)(q23;q11) | 3.1 | 20 | Citations (PDF) |
| 76 | Characterization of Five Novel Human Genes in the 11q13-q22 Region | 2.1 | 13 | Citations (PDF) |
| 77 | Duplications on Human Chromosome 22 Reveal a Novel Ret Finger Protein-Like Gene Family with Sense and Endogenous Antisense Transcripts | 4.7 | 33 | Citations (PDF) |
| 78 | Psoriasis Upregulated Phorbolin-1 Shares Structural but not Functional Similarity to the mRNA-Editing Protein Apobec-1 | 0.6 | 55 | Citations (PDF) |
| 79 | Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-MB constitutional deletion on chromosome 22: Possible localization of a neurofibromatosis type 2 modifier gene? 1999, 25, 184-190 | | 37 | Citations (PDF) |
| 80 | TOM1Genes Map to Human Chromosome 22q13.1 and Mouse Chromosome 8C1 and Encode Proteins Similar to the Endosomal Proteins HGS and STAM | 2.7 | 26 | Citations (PDF) |
| 81 | A 1-Mb PAC Contig Spanning the Common Eliminated Region 1 (CER1) in Microcell Hybrid-Derived SCID Tumors | 2.7 | 28 | Citations (PDF) |
| 82 | Genomic Structure, 5′ Flanking Sequences, and Precise Localization in 1P31.1 of the Human Prostaglandin F Receptor Gene | 2.1 | 17 | Citations (PDF) |
| 83 | The Mouse Ortholog of the HumanSMARCB1Gene Encodes Two Splice Forms | 2.1 | 28 | Citations (PDF) |
| 84 | Various regions within the alpha-helical domain of theCOL1A1 gene are fused to the second exon of thePDGFB gene in dermatofibrosarcomas and giant-cell fibroblastomas | 3.4 | 165 | Citations (PDF) |
| 85 | Characterization of the human NIPSNAP1 gene from 22q12: a member of a novel gene family | 2.4 | 49 | Citations (PDF) |
| 86 | A case of dermatofibrosarcoma protuberans with a ring chromosome 5 and a rearranged chromosome 22 containing amplified COL1A1 and PDGFB sequences | 8.5 | 35 | Citations (PDF) |
| 87 | Cloning, Expression Pattern, and Chromosomal Assignment to 16q23 of the Human γ-Adaptin Gene (ADTG) | 2.7 | 7 | Citations (PDF) |
| 88 | Deregulation of the platelet-derived growth factor β-chain gene via fusion with collagen gene COL1A1 in dermatof ibrosarcoma protuberans and giant-cell fibroblastoma | 26.1 | 538 | Citations (PDF) |
| 89 | Characterization of the mouse beta-prime adaptin gene; cDNA sequence, genomic structure, and chromosomal localization | 2.5 | 7 | Citations (PDF) |
| 90 | 1p and 3p deletions in meningiomas without detectable aberrations of chromosome 22 identified by comparative genomic hybridization 1997, 20, 419-424 | | 30 | Citations (PDF) |
| 91 | Regional Localization of over 300 Loci on Human Chromosome 22 Using a Somatic Cell Hybrid Mapping Panel | 2.7 | 28 | Citations (PDF) |
| 92 | Structure of the Promoter and Genomic Organization of the Human β′-Adaptin Gene (BAM22) from Chromosome 22q12 | 2.7 | 27 | Citations (PDF) |
| 93 | Sequence and Expression of the Mouse Homologue to Human Phospholipase C β3 Neighboring Gene | 2.1 | 10 | Citations (PDF) |
| 94 | Characterization of a second human clathrin heavy chain polypeptide gene (CLH-22) from chromosome 22q11 | 3.1 | 55 | Citations (PDF) |
| 95 | Isolation and mapping of cosmid markers on human chromosome 22, including one within the submicroscopically deleted region of DiGeorge syndrome | 3.1 | 30 | Citations (PDF) |
| 96 | Deletions on chromosome 22 in sporadic meningioma | 3.4 | 120 | Citations (PDF) |
| 97 | Chromosomal deletions in anaplastic meningiomas suggest multiple regions outside chromosome 22 as important in tumor progression | 4.5 | 93 | Citations (PDF) |
| 98 | Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas | 26.1 | 542 | Citations (PDF) |
| 99 | Physical Mapping of the NF2/Meningioma Region on Human Chromosome 22q12 | 2.7 | 18 | Citations (PDF) |
| 100 | Regional fine mapping of the β crystallin genes on chromosome 22 excludes these genes as physically linked markers for neurofibromatosis type 2 | 3.4 | 10 | Citations (PDF) |
| 101 | The Genes for Oncostatin M (OSM) and Leukemia Inhibitory Factor (LIF) Are Tightly Linked on Human Chromosome 22 | 2.7 | 54 | Citations (PDF) |
| 102 | Microdeletions within 22q11 associated with sporadic and familial DiGeorge syndrome | 2.7 | 246 | Citations (PDF) |
| 103 | A map of 22 loci on human chromosome 22 | 2.7 | 31 | Citations (PDF) |
| 104 | The Molecular Genetics of Meningiomas | 4.8 | 55 | Citations (PDF) |
| 105 | Isolation of anonymous, polymorphic DNA fragments from human chromosome 22q12-qter | 3.1 | 26 | Citations (PDF) |
